Saint Fargeau-Ponthierry, France

Alain Cuine

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2000-2005

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Alain Cuine

Introduction

Alain Cuine is a notable inventor based in Saint Fargeau-Ponthierry, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing innovative pharmaceutical compositions that enhance drug delivery and efficacy.

Latest Patents

Cuine's latest patents include a pharmaceutical composition with gastric residence and controlled release. This invention is characterized by its unique structure, comprising two or three layers. It contains an active principle associated with an excipient that modifies its release, along with a system generating carbon dioxide in a swelling polymer hydrophilic matrix. These components can be included in a common layer or in separate layers, showcasing Cuine's innovative approach to drug formulation. Another significant patent involves pharmaceutical compositions containing amisulpride and their therapeutic applications, further demonstrating his expertise in the pharmaceutical domain.

Career Highlights

Throughout his career, Alain Cuine has worked with prominent companies in the pharmaceutical industry, including Sanofi-Synthelabo and Synthelabo. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical technology.

Collaborations

Cuine has collaborated with notable colleagues such as Gérard Alaux and Frédéric Andre. These partnerships have played a crucial role in the development of his innovative pharmaceutical compositions.

Conclusion

Alain Cuine's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…